Noxopharm (ASX:NOX) reports 200-fold TLR8 amplification in human biopsies, backed by a US patent and Nature Immunology paper.
26
Stocks in Spotlight
View all →-
-
AI Stocks · Semiconductor stocks SanDisk (NASDAQ:SNDK) The Sell Case Behind a 3,300% AI Memory Rally May 21, 2026 -
AI Stocks · Blue Chip Stocks Life360 (ASX:360): Ad Revenue Jumped 329%, So Why Did the Stock Fall? May 12, 2026
